Global Vaccine Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

Published: November 2016
No. of Pages: 659
    ReportsandReports

The Global Vaccine Partnering Terms and Agreements 2010-2016: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in vaccine and adjuvant partnering deals
Deal terms analysis
Partnering agreement structure
Partnering contract documents
Top deals by value
Most active dealmakers
Average deal terms for vaccines

This report contains a comprehensive listing of all vaccine partnering deals announced since January 2010, including financial terms where available, including over 1,000 links to online deal records of actual vaccine partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The report takes readers through the vaccine deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering vaccine partnering deals.

The report presents average financial deal terms values for vaccine deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The middle section of the report explores the leaders in the vaccine partnering field; both the leading deal values and leading players are reported allowing readers to see who is succeeding in this growing market. This chapter also looks at the contributions by the big pharma and big biotech companies of the world in terms of deals made.

One of the key highlights of the report is that over 1,000 online deals records of actual vaccine deals as disclosed by the deal parties are included towards the end of the report in a directory format that is easy to reference. Each deal links via Weblink to an online version and all these deals are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), specific therapy and technology focus. In addition the report includes actual contract documents where available as submitted to the Securities Exchange Commission by companies and their deal partners.

Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

Finally the report concludes by looking into the future of vaccine partnering. With so many innovators looking for the next big thing in the field, the report selects companies to watch who are predicted to become big in the field based on their current dealmaking and financial trends.

Throughout the report various tables, figures and graphs are embedded in order to illustrate the trends and partnering activities of the vaccine field.

By the end of the report prospective dealmakers will have gained a thorough understanding of the partnering landscape of the vaccine market and will be familiar with the values and structures of the deals being signed within it.

Global Vaccine Partnering Terms and Agreements 2010-2016: Deal trends, players and financials is intended to provide the reader with an in-depth understanding and access to vaccine trends and structure of deals entered into by leading companies worldwide.

Global Vaccine Partnering Terms and Agreements 2010-2016: Deal trends, players and financials includes:

Trends in vaccine dealmaking in the biopharma industry since 2010
Analysis of vaccine deal structure
Access to headline, upfront, milestone and royalty data
Case studies of real-life vaccine deals
Access to over 1,000 vaccine deal documents
The leading vaccine deals by value since 2010
Most active vaccine dealmakers since 2010
The leading vaccine partnering resources

In Global Vaccine Partnering Terms and Agreements 2010-2016: Deal trends, players and financials, the available contracts are listed by:

Company A-Z
Headline value
Stage of development at signing
Deal component type
Therapy target
Specific technology type

Each deal title links via weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Vaccine Partnering Terms and Agreements 2010-2016: Deal trends, players and financials report provides comprehensive access to available deals and contract documents for over 880 vaccine deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise vaccine rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How are sales and payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?

Global Vaccine Partnering Terms and Agreements 2010-2016: Deal trends, players and financials provides the reader with the following key benefits:

In-depth understanding of vaccine and adjuvant deal trends since 2010
Access to headline, upfront, milestone and royalty data
Analysis of the structure of vaccine agreements with numerous real life case studies
Comprehensive access to over 1,000 actual vaccine deals entered into by the world’s biopharma companies, together with contract documents if available
Detailed access to actual vaccine contracts enter into by leading bio pharma companies
Identify leading vaccine deals by value since 2010
Identify the most active vaccine dealmakers since 2010
Insight into the terms included in a vaccine agreement, together with real world clause examples
Understand the key deal terms companies have agreed in previous deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Published By: Current Partnering
Product Code: Current Partnering229


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Related Reports:

  • Global Proline Market by Manufacturers, Regions, Type and Application, Forecast to 2021

    "Pharmaceuticals Additives Scientific Research" Scope of the Report: This report focuses on the Proline in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the m...

  • Global Peritoneal Dialysis Market by Manufacturers, Regions, Type and Application, Forecast to 2021

    Peritoneal Dialysis is a way of dialysis that use the body's own peritoneal as the dialysis membrane. It makes the dialysis solution injected into the intraperitoneal, the use of the human body peritoneal filter, clear the blood of metabolic wastes a...

  • Global Hydrogel Market by Manufacturers, Regions, Type and Application, Forecast to 2021

    Hydrogel is gel-like or colloidal substances made of water and solids. Hydrogels are highly absorbent polymeric networks, which contains over 90% water. It is widely used in medical fields, industrial fields, consumer goods etc. Scope of the Repor...

  • Europe Glimepiride Market Report 2016

    Notes: Sales, means the sales volume of Glimepiride Revenue, means the sales value of Glimepiride This report studies sales (consumption) of Glimepiride in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focus...

  • Europe Dolutegravir Market Report 2016

    Notes: Sales, means the sales volume of Dolutegravir Revenue, means the sales value of Dolutegravir This report studies sales (consumption) of Dolutegravir in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, fo...

  • Global Penicillin Market Professional Survey Report 2016

    Notes: Production, means the output of Penicillin Revenue, means the sales value of Penicillin This report studies Penicillin in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue...

  • Global Letrozole Market Professional Survey Report 2016

    Notes: Production, means the output of Letrozole Revenue, means the sales value of Letrozole This report studies Letrozole in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, c...

  • United States Sea Cucumber Capsule Market Report 2016

    Notes: Sales, means the sales volume of Sea Cucumber Capsule Revenue, means the sales value of Sea Cucumber Capsule This report studies sales (consumption) of Sea Cucumber Capsule in United States market, focuses on the top players, with sales, ...

  • Global Indomethacin Market Professional Survey Report 2016

    Notes: Production, means the output of Indomethacin Revenue, means the sales value of Indomethacin This report studies Indomethacin in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, r...

  • United States Veterinary Drugs Market Report 2016

    Notes: Sales, means the sales volume of Veterinary Drugs Revenue, means the sales value of Veterinary Drugs This report studies sales (consumption) of Veterinary Drugs in United States market, focuses on the top players, with sales, price, reven...


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Consumer Goods market as per your needs. Get the best of Consumer Goods research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: